Assuring the stability of therapeutic proteins is a major challenge in the biopharmaceutical industry, and a better molecular understanding of the mechanisms through which formulations influence their stability, is an ongoing priority. While the preferential exclusion effects of excipients are well known, the additional presence and impact of specific protein-excipient interactions has proven more elusive to identify and characterise. We have taken a combined approach of in-silico molecular docking, and hydrogen deuterium exchange mass spectrometry (HDX-MS), to characterise the interactions between Granulocyte Colony stimulating Factor (G-CSF), and some common excipients. These interactions were related to their influence on the thermalmelting temperatures (Tm), for the non-reversible unfolding of G-CSF in liquid formulations. The residue-level interaction sites predicted in silico, correlated well with those identified experimentally, and highlighted the potential impact of specific excipient interactions on the Tm of G-CSF.